BL derives from mature germinal or post germinal center B-cells and is further divided into three clinical entities (sporadic, endemic, and immunodeficiency-associated), all having in common rearrangements of the MYC oncogene. The gene discussed is MYC; the disease is Burkitt lymphoma.